Literature DB >> 19940513

Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study.

K T Wong1, J S Grove, A Grandinetti, J D Curb, M Yee, P Blanchette, G W Ross, B I Rodriguez.   

Abstract

BACKGROUND: The purpose of this prospective study was to examine whether fibrinogen level is associated with Parkinson disease (PD) for both prevalent and incident cases.
METHODS: The Honolulu Asia-Aging Study is a longitudinal study of Japanese-American men based on the Honolulu Heart Study birth cohort. The original cohort consisted of 8,006 participants with selective service records who were living on the island of Oahu, Hawaii, in 1965. For this analysis, baseline was defined as the 1991-1993 examination (n = 3,845) when men were aged 71-93 years old. Multivariate logistic regression and Cox proportional hazards models were used, adjusting for potential confounders.
RESULTS: We identified 61 prevalent cases and 61 incident cases of PD during the follow-up. High fibrinogen level (presence in the top quintile) was associated with higher frequency of PD for both prevalent (OR = 2.07, 95% CI = 1.10-3.88, p = 0.024) and incident cases (HR = 3.05, 95% CI = 1.34-6.97, p = 0.008) among men aged 76-93 years, after adjusting for age, smoking, and low-density lipoprotein cholesterol.
CONCLUSIONS: These results suggest high fibrinogen level is associated with increased risk of PD among men over 75 years. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940513      PMCID: PMC2818377          DOI: 10.1159/000260070

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  25 in total

1.  Research diagnostic criteria for Parkinson's disease.

Authors:  C D Ward; W R Gibb
Journal:  Adv Neurol       Date:  1990

2.  A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender.

Authors:  R Mayeux; J Denaro; N Hemenegildo; K Marder; M X Tang; L J Cote; Y Stern
Journal:  Arch Neurol       Date:  1992-05

3.  Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration.

Authors:  R M Worth; A Kagan
Journal:  J Chronic Dis       Date:  1970-11

4.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.

Authors:  R Mayeux; K Marder; L J Cote; J Denaro; N Hemenegildo; H Mejia; M X Tang; R Lantigua; D Wilder; B Gurland
Journal:  Am J Epidemiol       Date:  1995-10-15       Impact factor: 4.897

5.  Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.

Authors:  G Webster Ross; Helen Petrovitch; Robert D Abbott; James Nelson; William Markesbery; Daron Davis; John Hardman; Lenore Launer; Kamal Masaki; Caroline M Tanner; Lon R White
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

6.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.

Authors:  A Grandinetti; D M Morens; D Reed; D MacEachern
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

7.  Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters.

Authors:  H S Markus; A M Tomkins; G M Stern
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1993

8.  Prevalence of Parkinson's disease in the elderly: the Rotterdam Study.

Authors:  M C de Rijk; M M Breteler; G A Graveland; A Ott; D E Grobbee; F G van der Meché; A Hofman
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

9.  Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.

Authors:  Robert D Abbott; G Webster Ross; Lon R White; Wayne T Sanderson; Cecil M Burchfiel; Michael Kashon; Dan S Sharp; Kamal H Masaki; J David Curb; Helen Petrovitch
Journal:  J Neurol       Date:  2003-10       Impact factor: 4.849

10.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Authors:  Honglei Chen; Shumin M Zhang; Miguel A Hernán; Michael A Schwarzschild; Walter C Willett; Graham A Colditz; Frank E Speizer; Alberto Ascherio
Journal:  Arch Neurol       Date:  2003-08
View more
  12 in total

1.  Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health Study.

Authors:  Thanh G N Ton; Samay Jain; Mary L Biggs; Evan L Thacker; Elsa S Strotmeyer; Robert Boudreau; Anne B Newman; W T Longstreth; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2011-11-26       Impact factor: 4.891

Review 2.  Inflammatory mediators as biomarkers in brain disorders.

Authors:  Domenico Nuzzo; Pasquale Picone; Luca Caruana; Sonya Vasto; Annalisa Barera; Calogero Caruso; Marta Di Carlo
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

4.  Specific changes of serum proteins in Parkinson's disease patients.

Authors:  Wenwen Lu; Xinhua Wan; Bin Liu; Xianfang Rong; Lei Zhu; Pingping Li; Jiang Li; Ling Wang; Liying Cui; Xiaoliang Wang
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

5.  Particulate matter and risk of Parkinson disease in a large prospective study of women.

Authors:  Natalia Palacios; Kathryn C Fitzgerald; Jaime E Hart; Marc G Weisskopf; Michael A Schwarzschild; Alberto Ascherio; Francine Laden
Journal:  Environ Health       Date:  2014-10-07       Impact factor: 5.984

Review 6.  Inventory of real world data sources in Parkinson's disease.

Authors:  Audrey Tanguy; Linus Jönsson; Lianna Ishihara
Journal:  BMC Neurol       Date:  2017-12-08       Impact factor: 2.474

Review 7.  Is Porphyromonas gingivalis involved in Parkinson's disease?

Authors:  Ingar Olsen; Douglas B Kell; Etheresia Pretorius
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-21       Impact factor: 3.267

8.  Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Michael Malek-Ahmadi; Tyler A Kokjohn; Brittany N Dugger; Douglas G Walker; Holly A Shill; Sandra A Jacobson; Marwan N Sabbagh; Alex E Roher
Journal:  Biomark Insights       Date:  2013-03-12

9.  Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

Authors:  Shi-Xun Ma; Bo Am Seo; Donghoon Kim; Yulan Xiong; Seung-Hwan Kwon; Saurav Brahmachari; Sangjune Kim; Tae-In Kam; Raja Sekhar Nirujogi; Sang Ho Kwon; Valina L Dawson; Ted M Dawson; Akhilesh Pandey; Chan Hyun Na; Han Seok Ko
Journal:  J Proteome Res       Date:  2021-06-01       Impact factor: 4.466

10.  Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens.

Authors:  Büin Adams; J Massimo Nunes; Martin J Page; Timothy Roberts; Jonathan Carr; Theo A Nell; Douglas B Kell; Etheresia Pretorius
Journal:  Front Aging Neurosci       Date:  2019-08-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.